Simvastatin protects against the development of endometriosis in a nude mouse model
about
Pathogenesis of Endometriosis: Roles of Retinoids and Inflammatory PathwaysNovel therapies targeting endometriosisSimvastatin induces apoptosis and alters cytoskeleton in endometrial stromal cellsAnti-angiogenic treatment strategies for the therapy of endometriosis.Simvastatin increases the in vivo activity of the first-line tuberculosis regimen.Resveratrol inhibits development of experimental endometriosis in vivo and reduces endometrial stromal cell invasiveness in vitro.Simvastatin potently induces calcium-dependent apoptosis of human leiomyoma cells.Endometriosis: alternative methods of medical treatment.Novel effects of simvastatin on uterine fibroid tumors: in vitro and patient-derived xenograft mouse model study.Retinoic acid suppresses growth of lesions, inhibits peritoneal cytokine secretion, and promotes macrophage differentiation in an immunocompetent mouse model of endometriosis.Simvastatin decreases invasiveness of human endometrial stromal cells.Statins inhibit monocyte chemotactic protein 1 expression in endometriosis.Resveratrol potentiates effect of simvastatin on inhibition of mevalonate pathway in human endometrial stromal cells.Effects of simvastatin on retinoic acid system in primary human endometrial stromal cells and in a chimeric model of human endometriosis.Effects of simvastatin in prevention of pain recurrences after surgery for endometriosis.Medical management of endometriosis: emerging evidence linking inflammation to disease pathophysiologyInhibition of macrophage migration inhibitory factor reduces endometriotic implant size in mice with experimentally induced disease.New treatment strategies and emerging drugs in endometriosis.New trends for the medical treatment of endometriosis.The motile and invasive capacity of human endometrial stromal cells: implications for normal and impaired reproductive function.Statins as Targeted "Magical Pills" for the Conservative Treatment of Endometriosis: May Potential Adverse Effects on Female Fertility Represent the "Dark Side of the Same Coin"? A Systematic Review of Literature.Non-hormonal targets underlying endometriosis: A focus on molecular mechanisms.Experimental treatments of endometriosis.An overview of early drug development for endometriosis.Statin use and uterine fibroid risk in hyperlipidemia patients: a nested case-control study.Effect of simvastatin on monocyte chemoattractant protein-1 expression in endometriosis patients: a randomized controlled trial.Somatostatin analogs regress endometriotic implants in rats by decreasing implant levels of vascular endothelial growth factor and matrix metaloproteinase 9.Vascular endothelial growth factor C is increased in endometrium and promotes endothelial functions, vascular permeability and angiogenesis and growth of endometriosis.Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) as a potent anti-angiogenesis agent for endometriosis in mice.Effect of simvastatin on baboon endometriosis.Laparoscopic Surgery: A New Technique to Induce Endometriosis in a Mouse Model.Rodent Models of Experimental Endometriosis: Identifying Mechanisms of Disease and Therapeutic Targets.
P2860
Q28083420-D065D2A0-751E-4A13-A92C-28A8E97BBCBCQ33714186-3FAFA5C1-599D-47CD-90E3-7D50A02CDE2AQ34086658-9B4551C6-64E5-4415-B295-41088FB83F8EQ34283036-09746265-6E29-4F94-ACF9-BCEC546865C5Q34285683-DAFDEE40-F7A0-4FF7-ABEA-7E277F395A6CQ34450611-B92A7FE5-7D7A-47ED-96FF-4A282796BF72Q34737702-0D96997E-68A7-4CF7-97BC-C0668F274F14Q35668144-032E5860-F579-41A0-AFDB-AF3E13EEAC01Q35901096-6443FC13-7EA9-48E7-8B50-F746BA7A4810Q36007557-4175C8A1-1F69-45F1-B112-CC7CE05C9B48Q36121605-8DE49A3A-2375-41D0-8B5D-23B844DF3906Q36225986-4474ADDD-115A-40A2-873D-0240CC83BB17Q36663002-EB0136E6-08AB-4CD2-980D-131BF37B834FQ36663065-2E80BA2C-D753-4DF4-B18A-F5A50D931CBBQ36996906-128DBCA4-91FB-43E6-A636-0EFDA7E7B616Q37032251-4778FE6C-5FC0-4537-9D4C-53DD3F8D1170Q37727545-4D293F8C-8D7F-431F-BA86-21FE00314835Q37996102-14D1BA47-E75B-49CF-BE2A-0A133369E491Q38008481-F6CE6286-2B1E-4503-84A4-36307781C6E1Q38119393-6A420A1B-2F63-497D-AA4E-3C5A2F26AD10Q38451749-5B4F4F70-EEED-4255-8231-F965068DE919Q38486433-CDD0BC0D-BE55-4BB8-BB2D-EEF887A8CE56Q38575273-654F2792-C9C6-4816-8F85-D529E739ADD1Q38653393-32AA5B0A-8310-4716-A6BB-9453A3C0C960Q39637393-3F83E52B-3D2A-4566-AE79-3C17DADB45B4Q41670576-545496E9-CFB4-4562-A2CA-AF0107BC167AQ45037533-7F39AFF0-C23C-445D-841B-B614893563EFQ45090557-40832472-F200-4703-A3A5-2ABFE2E3E411Q45893632-CFA63B95-4504-4C54-94E9-3A40219BF4FFQ46205796-CC06862A-E3BB-47ED-A152-E88CD77F6DF8Q50918115-515997E1-DE6D-4607-9759-1E003273034DQ54962618-84B263DE-2352-40F2-AEBA-99DDB04627D1
P2860
Simvastatin protects against the development of endometriosis in a nude mouse model
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Simvastatin protects against the development of endometriosis in a nude mouse model
@en
Simvastatin protects against the development of endometriosis in a nude mouse model.
@nl
type
label
Simvastatin protects against the development of endometriosis in a nude mouse model
@en
Simvastatin protects against the development of endometriosis in a nude mouse model.
@nl
prefLabel
Simvastatin protects against the development of endometriosis in a nude mouse model
@en
Simvastatin protects against the development of endometriosis in a nude mouse model.
@nl
P2093
P2860
P356
P1476
Simvastatin protects against the development of endometriosis in a nude mouse model
@en
P2093
Antoni J Duleba
Kaylon L Bruner-Tran
Kevin G Osteen
P2860
P304
P356
10.1210/JC.2008-2802
P407
P577
2009-04-14T00:00:00Z